Epivario
Business Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
601 Walnut St Ste 715, Philadelphia, Pen...Phone Number
(215) 400-0133Website
www.epivario.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Epivario
EpiVario Inc. is an innovative biotechnology company focused on developing neuroepigenetic modulators to treat memory-related addictions and psychiatric disorders. Founded by leaders in neuroepigenetics, the company is pioneering epigenetic therapeutics aimed at addressing PTSD and substance use disorders through a novel approach that targets the epigenetic processes involved in long-term memory. EpiVario's research is rooted in the discovery of the ACSS2 enzyme, which plays a crucial role in memory formation and reconsolidation. The company aims to revolutionize treatments for various psychiatric disorders, including opioid, alcohol, and nicotine use disorders.Explore more
Epivario Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epivario your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Epivario recently announced quarterly report
Check if Epivario has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Epivario launches new products
Epivario, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Epivario
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Epivario has new funding data
Check out if Epivario is spiking on competitors!
Click to see if Epivario had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Epivario as Masked Content
Find 2 more new buyers
Compare Similar Companies to Epivario
Compare insights from companies similar to Epivario, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Epivario is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Epivario is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Epivario.
Epivario Tech Stack
A closer look at the technologies used by Epivario
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Executive Move
Executive Moves, Board of Directors
Executive Move
Epivario News & Media
EpiVario Awarded SBIR Grant From NIH to Develop Treatments for Opioid Use Disorder
EpiVario to receive $275,000 in funding from the National Institute on Drug Abuse PHILADELPHIA, Oct. 1, 2024 /PRNewswire/ -- EpiVario, Inc., a biotech company pioneering novel therapeutics for memory-related psychiatric disorders, today announced it has been awarded a small business...EpiVario Acquires Acetyl CoA Synthetase 2 Inhibitor Portfolio from Metabomed
EpiVario Inc., a biotech company pioneering neuroepigenetics to treat addiction disorders, today announced that it has entered into an asset... Read More The post EpiVario Acquires Acetyl CoA Synthetase 2 Inhibitor Portfolio from Metabomed appeared first on citybiz.EpiVario Announces Acquisition of Acetyl CoA Synthetase 2 (ACSS2) Inhibitor Portfolio from Metabomed LTD
Potent, selective ACSS2 inhibitory compounds with potential in CNS diseases PHILADELPHIA, Jan. 16, 2024 /PRNewswire/ -- EpiVario Inc., a biotech company pioneering neuroepigenetics to treat addiction disorders, today announced that it has entered into an asset purchase agreement with...EpiVario Appoints New Scientific Advisory Board Members and Expands Operations
Dr. Anthony Ford-Hutchinson and Dr. Paul Kenny bring valuable drug discovery and translational sciences expertise Company announces expansion of its Philadelphia operations PHILADELPHIA, Oct. 11, 2022 /PRNewswire/ -- EpiVario, a biotech company developing novel therapeutics for...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Epivario
Sign Up For FreeTo access detailed company insights
EpiVario Inc. is an innovative biotechnology company focused on developing neuroepigenetic modulators to treat memory-related addictions and psychiatric disorders. Founded by leaders in neuroepigenetics, the company is pioneering epigenetic therapeutics aimed at addressing PTSD and substance use disorders through a novel approach that targets the e... Read More
